INS and type 1 diabetes mellitus: In the Swedish ABIS cohort, oxPTM-INS-Ab were present in 82% children progressing to clinical T1D compared to 19% in those who did not progress despite having one or more standard islet-autoantibodies after a median follow-up of 10.8 years (interquartile range 7.7-12.8).